Cell Therapies Pty Ltd has been profiled in Australian Biotechnology’s most recent edition featuring advanced manufacturing. As cellular therapies transform healthcare for many unmet medical needs, new manufacturing capacity with unique skills in just-in-time production systems integrated with clinical point of care will be critical. CTPL provides this enabling infrastructure and with our founding partner and major shareholder Peter Mac we sit at the intersection of translational research, clinical trials and standard of care delivery. Contributing to both Victoria’s Future Industries Medical Technologies and Pharmaceuticals Advanced Manufacturing Strategy (http://yoursay.business.vic.gov.au/futureindustries/medical-technologies-pharmaceuticals) and the Victorian Health and Medical Research Strategy (http://www.health.vic.gov.au/healthandmedicalresearch/strategy) we are proud to be part of an advanced manufacturing eco-system that can be both a local manufacturing hub and employer and a significant exporter. The full journal can be found here: http://www.ausbiojournals.org/digimag/Oct2015/digimag.html
To view the article please click here AusBiotech Advanced Manufacturing CTPL Profile